SUBSCRIBE
SUBSCRIBE

BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
189 Results
Year
Month
Day
Year
Month
Day
  • RSS Feeds
    June 18, 2024
  • Becton, Dickinson and Company
    BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.
  • Ginkgo Bioworks
    At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more.
  • Roche
    Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
  • Biogen
    Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
  • Pictured: A scientist with pill bottles in front of FDA headquarters/Taylor Tieden for BioSpace
    FDA
    FDA Action Alert: Merck, Verona, AbbVie and Rocket
    The FDA is facing four big target action dates in the final week of June, including one label expansion for a bispecific antibody and another for an investigational gene therapy.
    June 18, 2024
     · 
    4 min read
     · 
    Tristan Manalac
  • Pictured: Photo illustration of hundred dollar bill and graph
    Decheng Capital Eyes $700M Raise for Fifth Life Sciences Fund as VC Heats Up
    On the heels of last week’s announcements from Foresite Capital and J.P. Morgan Private Capital, Decheng is planning to raise $700 million for its fifth life sciences fund.
    June 18, 2024
     · 
    2 min read
     · 
    Tristan Manalac
  • BIOSECURE’s Surprise Absence, the $100+ Billion Future Weight-Loss Market, DIA and More
    This week’s news ranged from BioSpace’s on-the-ground updates from DIA to safety concerns in clinical trials to BIOSECURE Act updates to new projections that the GLP-1 market could top $100 billion within 10 years.
    June 18, 2024
     · 
    2 min read
  • Pictured: AstraZeneca's manufacturing facility in Sweden
    Drug Development
    AstraZeneca’s Truqap Flops in Phase III Triple-Negative Breast Cancer Trial
    Bucking its recent winning streak in oncology, AstraZeneca reported Tuesday that its AKT inhibitor Truqap failed to significantly boost overall survival in patients with triple-negative breast cancer.
    June 18, 2024
     · 
    2 min read
     · 
    Tristan Manalac
  • Pictured: Exterior of Roche's facility in Boulogne-Billancourt, France
    Business
    Roche Inks Potential $1.8B Deal With Ascidian to Develop RNA Exon Therapies
    Ascidian Therapeutics will receive $42 million upfront from Roche, and up to $1.8 billion in milestone payments and royalties, to discover RNA exon editing candidates for neurological diseases.
    June 18, 2024
     · 
    2 min read
     · 
    Tyler Patchen